Articles On Sigma Healthcare (ASX:SIG)

Highlights Mixed analyst views highlight shifting sentiment across key stocks Sector-specific trends are shaping attention on select companies Market positioning differs across tech, mining and healthcare names Diverse sector tren...

There are plenty of options for investors on the local bourse. So many, it can be hard to decide which ones to buy over others. To narrow things down, let's take a look at whether analysts rate the popular ASX shares below as buys right now...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

Morgans has just upgraded its rating on ASX healthcare share Sigma Healthcare Ltd (ASX: SIG) due to ongoing share price weakness. The Sigma Healthcare share price is $2.73 on Friday, up 0.9% today but down 7.3% in the year to date (YTD)...

The Ides of March weighed down the sector, but green shoots of recovery may make April fools of the naysayers Telix Pharmaceuticals shares led the top end recovery with a 40% gain It’s April – and drug developers with names starting with ‘...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Greg Peel In a turbulent market, Sigma Healthcare could prove a defensive alternative driv...

The S&P/ASX 200 Index (ASX: XJO) is down 1.5% on Monday, with these five ASX 200 shares falling to new 52-week-plus lows. Two of the underperforming companies are in the technology sector, two are in healthcare, while the fifth is a ma...

It's interesting when one expert rates an ASX share as a buy. But, it's very intriguing when multiple analysts have a buy rating on that business. A lot has happened in the last few weeks as a result of the Middle East events, one of whi...

I think Sigma Healthcare Ltd (ASX: SIG) has quietly become one of the more interesting names on the S&P/ASX 200 Index (ASX: XJO). After completing its merger with Chemist Warehouse last year, the business now represents a scaled, int...

S&P/ASX 200 Health Care Index (ASX: XHJ) shares have crumbled 33% over 12 months, and not just because of CSL Ltd (ASX: CSL). While CSL's market capitalisation has halved over two years, several other sector heavyweights have also tu...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The Nasdaq Composite index fell -2.4% overnight, down more than -10% from its Octobe...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Markets are preparing for more positive signals from the fighting opponents in the M...

Broker Ord Minnett names its healthcare stocks likely to be high flyers during the current market rout Paradigm Biopharmaceuticals is close to halfway there in its pivotal knee trial – and more than Livin’ on a Prayer Lumos awaits crucial...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are suggesting a positive start on Wednesday, but CPI at 11am remains in...

Following all the drama of the last few weeks, a number of ASX shares are now trading at surprisingly low prices. We can't say what will happen in the next few weeks. But, I think the experience after 2020 and 2022 shows that the market...

Warren Buffett has always had a simple philosophy. Be greedy when others are fearful. Right now, there's definitely a lot of fear in the market. A number of high-quality ASX shares have been pushed down to 52-week lows or worse, no...

SpaceX Inc is expected to IPO it’s stock in 2026 – probably making Elon Musk even richer than his current $800 billion net worth. Is the SpaceX IPO something worth researching? I – Owen Rask, founder of Rask and a real space nerd – took a l...

ASX share prices are always changing, which means investors have the opportunity to buy and sell at different times. When share prices are at their cheapest, those low valuations often coincide with the market becoming afraid of somethin...

The prices we're seeing now and in the coming weeks could be some of the best value ASX shares available to investors this year, or even the rest of the decade. It's not often that share prices go through a decline of 10% or more. Widesp...

Highlights ASX 200 declines continue amid cautious sentiment Resource stocks face pressure while energy shows resilience Defensive sectors attract attention during volatility Australian equities faced continued pressur...

The S&P/ASX 200 Index (ASX: XJO) ended what has been a brutal week of trading with another loss this Friday. After yesterday's horrid 1.7% drop, investors weren't in the mood to turn the ship around today. The ASX 200 spent the entire s...

There's no shortage of opportunities on the ASX right now. But rather than trying to chase what's hot, I prefer to focus on businesses that are executing well, growing consistently, and have clear long-term potential. Here are four to...

At first glance, the Australian share market doesn't look particularly cheap. Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is still sitting not far from record hig...

I'm excited about the potential behind Australian stocks looking to go global with their growth. Australia is a great country to do business in, but with less than 30 million people in Australia it's important to recognise there are othe...

ASX health sector falls about 2.5% for the past five days while broader market is just scraping by as the Middle East conflict takes a toll Immutep plunges 90% on Friday after abandoning its Phase III trial of lung cancer treatment  Pro Me...

Many investors eventually reach a point where they have some spare cash ready to put into the share market. Whether that money is being used to start a new position, add to an existing holding, or simply take advantage of opportunities...

Some companies are built to benefit from short-term trends. Others are built to endure. When I think about ASX 200 shares I could happily hold for decades, I usually look for businesses with strong competitive positions, long growth runw...

Seeing a company hit a 52-week low can make investors nervous. But in many cases, those moments can create opportunities rather than warnings. Here are three ASX 200 shares currently trading near their lows that I think could be worth co...

ASX health sector flat for the week, while the S&P/ASX 200 falls xx% as Middle East conflict takes a toll on global markets LTR Pharma completes recruitment for a phase II pharmacokinetic clinical study of erectile dysfunction treatmen...

Investing for the next five years doesn't require predicting every twist in the market. What matters more, in my view, is owning businesses with durable advantages, solid growth prospects, and management teams that know how to allocate c...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets recovered off intraday lows on confirmation the US Administration is taki...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and tumbled lower. The benchmark index fell 1.35% to 9,077.3 points. Will the market be able to bounce back from this on Wednesday? Here are five things to watch: ASX 200 to...

S&P/ASX 200 Index (ASX: XJO) shares closed 1.34% lower at 9,077.3 points yesterday, after matching Monday's record high of 9,200.9 points during intraday trading. The market took a breather yesterday to assess the impact of the US a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets recounded off intraday lows with technology stocks finding buying support...

The team at Morgans has been busy reviewing the countless results released last month. Let's see what the broker is saying about the popular ASX shares listed below and whether it thinks there's a buying opportunity here for investors. Here...

S&P/ASX 200 Index (ASX: XJO) blue-chip shares can deliver strong and resilient earnings thanks to their market position, margins, and brand power. I'm not particularly attracted to ASX mining or bank shares, but there are other ind...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets were weaker on Friday, but all eyes are now focused on Iran and the Middl...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

The local healthcare sector fell 1.6% this week as reporting season continued Sigma delivered “solid” first-half results underscoring its merger with Chemist Warehouse  Ramsay soared after its H1 FY26 profit beat forecasts with NPAT of $17...

Sigma Healthcare Ltd (ASX: SIG) shares were bouncing around on Thursday. The Chemist Warehouse owner's shares were up as high as $3.20, just short of a 52-week high, before closing down at $2.94. Should you be taking advantage of the pullba...

February may have included Valentine’s Day, but investors didn’t show a great deal of love for our revenue-generating healthcare stocks Companies producing ambivalent results were whacked while the poor performers were hit even harder But...

Discount pharmacy juggernaut Chemist Warehouse has attributed its double-digit sales lift to the growing popularity of weight-loss drugs like Ozempic and Mounjaro.

Back-to-back record closes for S&P/ASX 200 Index on track for strongest month in nine months Nvidia fireworks and miner muscle drive gains   The S&P/ASX 200 notched a second straight record close on Thursday, rising 0.51% to 9175...

Highlights Technology strength steadies market tone Healthcare activity improves sentiment Industrial pressure reshapes outlook Sector rotation shaped Australian equities as technology and healthcare strength offset in...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Thursday and charging higher. In afternoon trade, the benchmark index is up 0.6% to 9,182.2 points. Four ASX shares that are rising more than most today are listed below. Here's why...

Sigma Health expects ongoing benefit from GLP-1 prescriptions, rather than a peripheral “RAT test” effect Alcidion posts record first half revenues Nova eyes earnings breakeven in the second half   Anti-obesity drug prescriptions have pla...

Sigma Healthcare Ltd (ASX: SIG) shares are having a strong start to the day. In morning trade, the Chemist Warehouse owner's shares are up 7% to $3.20. This follows the release of another strong half-year result from the retail pharmacy fra...

The DroneShield Ltd (ASX: DRO) share price is in focus after announcing a package of six contracts totalling $21.7 million with a western military end-customer. The contracts cover dismounted counter-drone systems, spares, and software, wit...

The Atlas Arteria Group (ASX: ALX) share price is in focus today after the company unveiled its 2025 full‑year results, which saw a 9.4% lift in proportional toll revenue and a reaffirmed distribution guidance. What did Atlas Arteria repo...

The Sigma Healthcare Ltd (ASX: SIG) share price is in focus today after the company reported 1H26 revenue of $5.5 billion (up 14.9%) and normalised NPAT of $392 million (up 19.2%). What did Sigma Healthcare report? Revenue increased 14.9%...